GLOBUS MEDICAL INC - Class A Stock (GMED)

Historical Holders from Q1 2014 to Q3 2025

Symbol
GMED on NYSE
Type / Class
Equity / Class A Stock
Shares outstanding
115M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
116M
Holdings value
$6.65B
% of all portfolios
0.014%
Grand Portfolio weight change
+0%
Number of holders
484
Number of buys
245
Number of sells
-243
Average Value change %
+0%
Average buys %
+0.003%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of GLOBUS MEDICAL INC - Class A Stock (GMED)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 9.1% +16.3% $779M -$11.1M 10.5M -1.4% BlackRock, Inc. 31 Mar 2025
JANUS HENDERSON GROUP PLC 6.1% +5% $522M $30.8M 7.03M +6.27% JANUS HENDERSON GROUP PLC 31 Mar 2025

Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 116M $6.65B +$67.5M $57.27 484
2025 Q2 114M $6.73B +$196M $59.02 477
2025 Q1 109M $8B -$8.99M $73.20 507
2024 Q4 109M $9.01B +$44.3M $82.71 495
2024 Q3 108M $7.73B -$332M $71.54 444
2024 Q2 113M $7.72B -$3.14M $68.49 443
2024 Q1 113M $6.08B +$359M $53.64 435
2023 Q4 107M $5.69B -$156M $53.29 405
2023 Q3 109M $5.43B +$1.36B $49.65 426
2023 Q2 81.4M $4.84B +$409M $59.54 378
2023 Q1 74.6M $4.22B -$151M $56.64 381
2022 Q4 75.9M $5.64B +$86.7M $74.27 383
2022 Q3 74.5M $4.44B +$100M $59.57 356
2022 Q2 72.2M $4.05B +$112M $56.14 349
2022 Q1 69.5M $5.13B +$81M $73.78 366
2021 Q4 68.3M $4.94B +$7.51M $72.20 367
2021 Q3 67.7M $5.19B -$70M $76.62 380
2021 Q2 68M $5.28B +$27.1M $77.53 351
2021 Q1 67.7M $4.18B +$52.8M $61.67 338
2020 Q4 66.6M $4.34B +$138M $65.22 343
2020 Q3 64.4M $3.19B -$116M $49.52 336
2020 Q2 66.7M $3.18B -$236M $47.71 312
2020 Q1 71.8M $3.05B +$121M $42.53 266
2019 Q4 67.3M $3.96B -$28.8M $58.88 304
2019 Q3 68.1M $3.48B +$23.2M $51.12 266
2019 Q2 67.9M $2.87B +$68.3M $42.30 255
2019 Q1 66.7M $3.29B -$65.7M $49.41 264
2018 Q4 68.2M $2.95B +$98.5M $43.28 301
2018 Q3 65.5M $3.72B +$107M $56.76 310
2018 Q2 63.7M $3.21B +$91.3M $50.46 285
2018 Q1 62M $3.08B -$55.5M $49.82 276
2017 Q4 63.3M $2.6B -$178M $41.10 254
2017 Q3 68.8M $2.04B +$133M $29.72 247
2017 Q2 63.9M $2.11B -$6.74M $33.15 240
2017 Q1 66.4M $1.97B +$212M $29.62 240
2016 Q4 66.4M $1.65B +$49.8M $24.81 204
2016 Q3 65.1M $1.47B -$90.1M $22.57 191
2016 Q2 68.9M $1.64B +$5.9M $23.83 203
2016 Q1 69.5M $1.65B +$41M $23.75 200
2015 Q4 66.2M $1.84B +$9.16M $27.82 185
2015 Q3 66.6M $1.38B +$85.5M $20.66 178
2015 Q2 62.5M $1.61B -$1.85M $25.67 177
2015 Q1 62.7M $1.58B +$33.7M $25.24 178
2014 Q4 61.3M $1.46B +$92.4M $23.77 181
2014 Q3 57.2M $1.12B +$35.4M $19.67 163
2014 Q2 54.4M $1.3B +$4.05M $23.92 174
2014 Q1 53.2M $1.41B +$60.4M $26.59 157